Literature DB >> 27933351

[Modern modifications of uvulopalatopharyngoplasty].

T Verse1,2, B A Stuck3.   

Abstract

Uvulopalatopharyngoplasty (UPPP) was first described in 1964 with regard to surgical treatment of snoring and in 1981 with regard to treatment of obstructive sleep apnea (OSA). The initial surgical techniques for OSA were very invasive, frequently leading to significant morbidity and complications. Wolfgang Pirsig et al. were the first in Germany to recognize that a radical surgical technique increased only the complications, not the efficacy of UPPP. The less invasive surgical technique developed based on these findings is still established in Germany. A meta-analysis from 1996 described a success rate of UPPP of about 50%. High-quality randomized trials demonstrate significant superiority of UPPP plus tonsillectomy compared to untreated controls. However, the objective outcome measures of classic UPPP could not be improved even with additional patient selection criteria, and the effects of UPPP often deteriorate over time. To overcome these limitations, various modifications of UPPP have been developed. Due to limited data, evaluation of these new techniques and their comparison with conventional UPPP is difficult at present. In studies comparing a modification of UPPP with the standard approach, the tested modification was demonstrated to be superior. A relevant limitation of the available data results from the small number of institutions (usually not more than two) that investigated the respective modification and the follow-up periods of usually only 6 months. Data are also too sparse to reliably assess complication rates. For conventional UPPP there are considerably more data, wider experience with long-term outcome, and more robust studies examining treatment effects beyond basic respiratory parameters. At present, modifications of UPPP should be principally employed in clinical trials.

Entities:  

Keywords:  Complications; Obstructive sleep apnea; Otorhinolaryngologic surgical procedures; Soft palate; Uvula

Mesh:

Year:  2017        PMID: 27933351     DOI: 10.1007/s00106-016-0300-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  35 in total

1.  Prediction of uvulopalatopharyngoplasty outcome: anatomy-based staging system versus severity-based staging system.

Authors:  Hsueh-Yu Li; Pa-Chun Wang; Li-Ang Lee; Ning-Hung Chen; Tuan-Jen Fang
Journal:  Sleep       Date:  2006-12       Impact factor: 5.849

Review 2.  Update on surgical treatments for sleep apnea.

Authors:  Joachim T Maurer
Journal:  Swiss Med Wkly       Date:  2009-10-31       Impact factor: 2.193

3.  Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.

Authors:  C E Sullivan; F G Issa; M Berthon-Jones; L Eves
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

4.  Associated predictors of therapeutic response to uvulopharyngopalatoplasty for severe obstructive sleep apnea hypopnea syndrome.

Authors:  Su Ru Liu; Hong Liang Yi; Shan Kai Yin; Jian Guan; Bin Chen; Li Li Meng; Kai Ming Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-27       Impact factor: 2.503

Review 5.  The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome.

Authors:  A E Sher; K B Schechtman; J F Piccirillo
Journal:  Sleep       Date:  1996-02       Impact factor: 5.849

6.  Lateral pharyngoplasty versus uvulopalatopharyngoplasty: a clinical, polysomnographic and computed tomography measurement comparison.

Authors:  Michel B Cahali; Gilberto G S Formigoni; Eloisa M M S Gebrim; Ivan D Miziara
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

7.  Lateral pharyngoplasty reduces nocturnal blood pressure in patients with obstructive sleep apnea.

Authors:  Carolina F de Paula Soares; Luciano Cavichio; Michel B Cahali
Journal:  Laryngoscope       Date:  2013-09-19       Impact factor: 3.325

8.  Tonsillectomy with Uvulopalatopharyngoplasty in Obstructive Sleep Apnea.

Authors:  Ulrich J Sommer; Clemens Heiser; Constanze Gahleitner; Raphael M Herr; Karl Hörmann; Joachim T Maurer; Boris A Stuck
Journal:  Dtsch Arztebl Int       Date:  2016-01-11       Impact factor: 5.594

9.  Computer-assisted quantitative upper airway analysis following modified uvulopalatal flap and lateral pharyngoplasty for obstructive sleep apnoea: a prospective case-controlled study.

Authors:  P P Hsu; A K L Tan; E C Gan; Y H Chan; M M Goh; P K S Lu; W L Howe
Journal:  Clin Otolaryngol       Date:  2012-06       Impact factor: 2.597

10.  SKUP3 randomised controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea.

Authors:  Nanna Browaldh; Pia Nerfeldt; Michael Lysdahl; Johan Bring; Danielle Friberg
Journal:  Thorax       Date:  2013-05-05       Impact factor: 9.139

View more
  4 in total

Review 1.  Palate surgery for obstructive sleep apnea: a 17-year meta-analysis.

Authors:  Kenny Peter Pang; Guillermo Plaza; Peter M Baptista J; Carlos O'Connor Reina; Yiong Huak Chan; Kathleen A Pang; Edward B Pang; Cybil Mei Zhi Wang; Brian Rotenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-25       Impact factor: 2.503

2.  Comparison of two surgical suture techniques in uvulopalatopharyngoplasty and expansion sphincter pharyngoplasty.

Authors:  Teresa B Steinbichler; Birte Bender; Aristeidis I Giotakis; Daniel Dejaco; Christoph Url; Herbert Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-21       Impact factor: 2.503

3.  Complete concentric collapse at the soft palate in sleep endoscopy: what change is possible after UPPP in patients with CPAP failure?

Authors:  Katrin Hasselbacher; A Seitz; N Abrams; B Wollenberg; A Steffen
Journal:  Sleep Breath       Date:  2018-05-16       Impact factor: 2.816

4.  Evaluation of a nasopharyngeal stent in patients with obstructive sleep-related breathing disorders.

Authors:  Alexander Dellweg; Martin Kampmann; Kurt Tschopp
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.